KAICO Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 50

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $3.65M

  • Investors
  • 17

KAICO General Information

Description

Developer of silkworm-expressed protein technologies enabling safer and more sustainable biomanufacturing. The company leverages silkworm-based expression systems to produce complex proteins with high efficiency and reduced environmental impact, enabling pharmaceutical, biotechnology and industrial partners to access an alternative to conventional cell culture platforms.

Contact Information

Website
www.kaicoltd.jp
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4-1, Kyudaishinmachi, Nishi ku
  • Fukuoka, Fukuoka 819-0388
  • Japan
+81
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Discovery Tools (Healthcare)
Vertical(s)
Manufacturing, AgTech, HealthTech, Life Sciences
Corporate Office
  • 4-1, Kyudaishinmachi, Nishi ku
  • Fukuoka, Fukuoka 819-0388
  • Japan
+81

KAICO Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

KAICO Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series B) 15-Apr-2025 $3.65M Completed Generating Revenue
8. Later Stage VC (Series A) 19-Jan-2024 Completed Generating Revenue
7. Accelerator/Incubator 21-Sep-2022 Completed Generating Revenue
6. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
5. Early Stage VC (Series A2) 15-Dec-2021 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2021 Completed Startup
3. Early Stage VC (Series A) 22-May-2020 Completed Startup
2. Accelerator/Incubator 06-Sep-2019 $354K Completed Startup
1. Seed Round 26-Oct-2018 $354K $354K Completed Startup
To view KAICO’s complete valuation and funding history, request access »

KAICO Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Class B preferred
A3 Shares
A2 Shares 130,000 $13.52 $13.52 1x $13.52 13.1%
A Shares 152,894 $11.49 $11.49 1x $11.49 15.41%
To view KAICO’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

KAICO Patents

  • 16

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 11

    Pending

  • Expiring in next 12 mo

KAICO Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026140419-A1 Oral vaccine composition against feline viral infection virus Pending 27-Dec-2024
AU-2023280661-A1 Oral vaccine composition Pending 02-Jun-2022
EP-4534098-A1 Oral vaccine composition Pending 02-Jun-2022
JP-7502739-B2 Oral vaccine composition Active 02-Jun-2022
US-20250325647-A1 Oral vaccine composition Pending 02-Jun-2022 A61K39/12
To view KAICO’s complete patent history, request access »

KAICO Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KAICO Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Agribusiness Investment & Development Venture Capital Minority
DG Ventures Corporate Venture Capital Minority
Higin Capital Investment Bank Minority
JMTC Capital Corporate Venture Capital Minority
Sagin Capital & Consulting Venture Capital Minority
You’re viewing 5 of 17 investors. Get the full list »

Ready to get started?

Request a free trial

KAICO FAQs

  • When was KAICO founded?

    KAICO was founded in 2018.

  • Where is KAICO headquartered?

    KAICO is headquartered in Fukuoka, Japan.

  • What is the size of KAICO?

    KAICO has 50 total employees.

  • What industry is KAICO in?

    KAICO’s primary industry is Biotechnology.

  • Is KAICO a private or public company?

    KAICO is a Private company.

  • What is the current valuation of KAICO?

    The current valuation of KAICO is .

  • What is KAICO’s current revenue?

    The current revenue for KAICO is .

  • How much funding has KAICO raised over time?

    KAICO has raised $10.7M.

  • Who are KAICO’s investors?

    Agribusiness Investment & Development, DG Ventures, Higin Capital, JMTC Capital, and Sagin Capital & Consulting are 5 of 17 investors who have invested in KAICO.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process